APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Autacoids and Related Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Autacoids and Related Drugs Industry Growth and Trends Forecast to 2032

Report ID 173968320127 December 202590 pages

Choose your research edition.

Industry ResearchAutacoids and Related Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Autacoids and Related Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Autacoids and Related Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autacoids and Related Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Autacoids and Related Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Autacoids and Related Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autacoids and Related Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Autacoids and Related Drugs include Sanofi, AstraZeneca, Fresenius, Bristol-Myers Squibb, Bedford Laboratories and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Autacoids and Related Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Autacoids and Related Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autacoids and Related Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autacoids and Related Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Autacoids and Related Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Autacoids and Related Drugs Market by Company

Sanofi

AstraZeneca

Fresenius

Bristol-Myers Squibb

Bedford Laboratories

Abbott Laboratories

Autacoids and Related Drugs Segment by Type

Polypeptides

Eicosanoids

Decarboxylated Amino Acids

Autacoids and Related Drugs Segment by Application

Allergies

Chronic Pain

Neuroendocrine Regulation

Gastrointestinal Diseases

Gastric Acid Secretion

Cardiovascular Diseases

Inflammation

Autacoids and Related Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autacoids and Related Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autacoids and Related Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autacoids and Related Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Autacoids and Related Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Autacoids and Related Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polypeptides Table 2. Major Company of Eicosanoids Table 3. Major Company of Decarboxylated Amino Acids Table 4. Global Autacoids and Related Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 6. Global Autacoids and Related Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Autacoids and Related Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Autacoids and Related Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Autacoids and Related Drugs Sales by Type (2027-2032) & (W Units) Table 11. Global Autacoids and Related Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Autacoids and Related Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Autacoids and Related Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Autacoids and Related Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 16. North America Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 18. Europe Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 22. Latin America Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Autacoids and Related Drugs Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Autacoids and Related Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Autacoids and Related Drugs Industry Trends Table 26. Autacoids and Related Drugs Industry Drivers Table 27. Autacoids and Related Drugs Industry Opportunities and Challenges Table 28. Autacoids and Related Drugs Industry Restraints Table 29. Global Autacoids and Related Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Autacoids and Related Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Autacoids and Related Drugs Sales by Company (2021-2026) & (W Units) Table 32. Global Autacoids and Related Drugs Sales Share by Company (2021-2026) Table 33. Global Autacoids and Related Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Autacoids and Related Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Autacoids and Related Drugs Major Company Production Sites and Headquarters Table 36. Global Autacoids and Related Drugs Company, Product Type & Application Table 37. Global Autacoids and Related Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Autacoids and Related Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Autacoids and Related Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Autacoids and Related Drugs Sales by Region (2021-2026) & (W Units) Table 42. Global Autacoids and Related Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Autacoids and Related Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Autacoids and Related Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Autacoids and Related Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Autacoids and Related Drugs Sales by Region (2027-2032) & (W Units) Table 47. Global Autacoids and Related Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Autacoids and Related Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Autacoids and Related Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Autacoids and Related Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Autacoids and Related Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 53. Global Autacoids and Related Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Autacoids and Related Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Autacoids and Related Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Autacoids and Related Drugs Sales by Application (2027-2032) & (W Units) Table 58. Global Autacoids and Related Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Autacoids and Related Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Autacoids and Related Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Autacoids and Related Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 63. North America Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 65. Europe Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 69. Latin America Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Autacoids and Related Drugs Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Autacoids and Related Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Autacoids and Related Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AstraZeneca Autacoids and Related Drugs Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Fresenius Company Information Table 83. Fresenius Business Overview Table 84. Fresenius Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Fresenius Autacoids and Related Drugs Product Portfolio Table 86. Fresenius Recent Development Table 87. Bristol-Myers Squibb Company Information Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Autacoids and Related Drugs Product Portfolio Table 91. Bristol-Myers Squibb Recent Development Table 92. Bedford Laboratories Company Information Table 93. Bedford Laboratories Business Overview Table 94. Bedford Laboratories Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bedford Laboratories Autacoids and Related Drugs Product Portfolio Table 96. Bedford Laboratories Recent Development Table 97. Abbott Laboratories Company Information Table 98. Abbott Laboratories Business Overview Table 99. Abbott Laboratories Autacoids and Related Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Abbott Laboratories Autacoids and Related Drugs Product Portfolio Table 101. Abbott Laboratories Recent Development Table 102. North America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 103. North America Autacoids and Related Drugs Sales by Country (2021-2026) & (W Units) Table 104. North America Autacoids and Related Drugs Sales Market Share by Country (2021-2026) Table 105. North America Autacoids and Related Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 106. North America Autacoids and Related Drugs Sales Market Share Forecast by Country (2027-2032) Table 107. North America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Autacoids and Related Drugs Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Autacoids and Related Drugs Market Share by Country (2021-2026) Table 110. North America Autacoids and Related Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Autacoids and Related Drugs Market Share Forecast by Country (2027-2032) Table 112. Europe Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 113. Europe Autacoids and Related Drugs Sales by Country (2021-2026) & (W Units) Table 114. Europe Autacoids and Related Drugs Sales Market Share by Country (2021-2026) Table 115. Europe Autacoids and Related Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 116. Europe Autacoids and Related Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Autacoids and Related Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Autacoids and Related Drugs Market Share by Country (2021-2026) Table 120. Europe Autacoids and Related Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Autacoids and Related Drugs Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Autacoids and Related Drugs Sales by Country (2021-2026) & (W Units) Table 124. Asia-Pacific Autacoids and Related Drugs Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Autacoids and Related Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 126. Asia-Pacific Autacoids and Related Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Autacoids and Related Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Autacoids and Related Drugs Market Share by Country (2021-2026) Table 130. Asia-Pacific Autacoids and Related Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Autacoids and Related Drugs Market Share Forecast by Country (2027-2032) Table 132. Latin America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Latin America Autacoids and Related Drugs Sales by Country (2021-2026) & (W Units) Table 134. Latin America Autacoids and Related Drugs Sales Market Share by Country (2021-2026) Table 135. Latin America Autacoids and Related Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 136. Latin America Autacoids and Related Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Autacoids and Related Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Autacoids and Related Drugs Market Share by Country (2021-2026) Table 140. Latin America Autacoids and Related Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Autacoids and Related Drugs Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Autacoids and Related Drugs Sales by Country (2021-2026) & (W Units) Table 144. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Autacoids and Related Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 146. Middle East and Africa Autacoids and Related Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Autacoids and Related Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Autacoids and Related Drugs Market Share by Country (2021-2026) Table 150. Middle East and Africa Autacoids and Related Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Autacoids and Related Drugs Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Autacoids and Related Drugs Distributors List Table 155. Autacoids and Related Drugs Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Autacoids and Related Drugs Image Figure 2. Global Autacoids and Related Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autacoids and Related Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Autacoids and Related Drugs Sales (2021-2032) & (W Units) Figure 5. Polypeptides Image Figure 6. Global Polypeptides Sales YoY Growth (2021-2032) & (W Units) Figure 7. Eicosanoids Image Figure 8. Global Eicosanoids Sales YoY Growth (2021-2032) & (W Units) Figure 9. Decarboxylated Amino Acids Image Figure 10. Global Decarboxylated Amino Acids Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Autacoids and Related Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Autacoids and Related Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Autacoids and Related Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Autacoids and Related Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Autacoids and Related Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Autacoids and Related Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Autacoids and Related Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Autacoids and Related Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Autacoids and Related Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Autacoids and Related Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Autacoids and Related Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Autacoids and Related Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Autacoids and Related Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Allergies Image Figure 26. Global Allergies Sales YoY Growth (2021-2032) & (W Units) Figure 27. Chronic Pain Image Figure 28. Global Chronic Pain Sales YoY Growth (2021-2032) & (W Units) Figure 29. Neuroendocrine Regulation Image Figure 30. Global Neuroendocrine Regulation Sales YoY Growth (2021-2032) & (W Units) Figure 31. Gastrointestinal Diseases Image Figure 32. Global Gastrointestinal Diseases Sales YoY Growth (2021-2032) & (W Units) Figure 33. Gastric Acid Secretion Image Figure 34. Global Gastric Acid Secretion Sales YoY Growth (2021-2032) & (W Units) Figure 35. Cardiovascular Diseases Image Figure 36. Global Cardiovascular Diseases Sales YoY Growth (2021-2032) & (W Units) Figure 37. Inflammation Image Figure 38. Global Inflammation Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Autacoids and Related Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Autacoids and Related Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Autacoids and Related Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Autacoids and Related Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Autacoids and Related Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Autacoids and Related Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Autacoids and Related Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Autacoids and Related Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Autacoids and Related Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Autacoids and Related Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Autacoids and Related Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Autacoids and Related Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Autacoids and Related Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Autacoids and Related Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Autacoids and Related Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Autacoids and Related Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Autacoids and Related Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Autacoids and Related Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Autacoids and Related Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Autacoids and Related Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Autacoids and Related Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Autacoids and Related Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Autacoids and Related Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Autacoids and Related Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Autacoids and Related Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Autacoids and Related Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Autacoids and Related Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Autacoids and Related Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Autacoids and Related Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Autacoids and Related Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Autacoids and Related Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Autacoids and Related Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Autacoids and Related Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Autacoids and Related Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Polypeptides
  • Eicosanoids
  • Decarboxylated Amino Acids
Applications
  • Allergies
  • Chronic Pain
  • Neuroendocrine Regulation
  • Gastrointestinal Diseases
  • Gastric Acid Secretion
  • Cardiovascular Diseases
  • Inflammation
Companies covered
  • Sanofi
  • AstraZeneca
  • Fresenius
  • Bristol-Myers Squibb
  • Bedford Laboratories
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Autacoids and Related Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Autacoids and Related Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Autacoids and Related Drugs Market by Type
  6. 1.3.1 Polypeptides
  7. 1.3.2 Eicosanoids
  8. 1.3.3 Decarboxylated Amino Acids
  9. 1.4 Global Autacoids and Related Drugs Market Size by Type
  10. 1.4.1 Global Autacoids and Related Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Autacoids and Related Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Autacoids and Related Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Autacoids and Related Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Autacoids and Related Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Autacoids and Related Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Autacoids and Related Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Autacoids and Related Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Autacoids and Related Drugs Industry Trends
  2. 2.2 Autacoids and Related Drugs Industry Drivers
  3. 2.3 Autacoids and Related Drugs Industry Opportunities and Challenges
  4. 2.4 Autacoids and Related Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Autacoids and Related Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Autacoids and Related Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Autacoids and Related Drugs Price (2021-2026)
  4. 3.4 Global Autacoids and Related Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Autacoids and Related Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Autacoids and Related Drugs Company, Product Type & Application
  7. 3.7 Global Autacoids and Related Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Autacoids and Related Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Autacoids and Related Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Autacoids and Related Drugs Tier 1, Tier 2, and Tier 3
4 Autacoids and Related Drugs Regional Status and Outlook
  1. 4.1 Global Autacoids and Related Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Autacoids and Related Drugs Historic Market Size by Region
  3. 4.2.1 Global Autacoids and Related Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Autacoids and Related Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Autacoids and Related Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Autacoids and Related Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Autacoids and Related Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Autacoids and Related Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Autacoids and Related Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Autacoids and Related Drugs by Application
  1. 5.1 Autacoids and Related Drugs Market by Application
  2. 5.1.1 Allergies
  3. 5.1.2 Chronic Pain
  4. 5.1.3 Neuroendocrine Regulation
  5. 5.1.4 Gastrointestinal Diseases
  6. 5.1.5 Gastric Acid Secretion
  7. 5.1.6 Cardiovascular Diseases
  8. 5.1.7 Inflammation
  9. 5.2 Global Autacoids and Related Drugs Market Size by Application
  10. 5.2.1 Global Autacoids and Related Drugs Market Size Overview by Application (2021-2032)
  11. 5.2.2 Global Autacoids and Related Drugs Historic Market Size Review by Application (2021-2026)
  12. 5.2.3 Global Autacoids and Related Drugs Forecasted Market Size by Application (2027-2032)
  13. 5.3 Key Regions Market Size by Application
  14. 5.3.1 North America Autacoids and Related Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.2 Europe Autacoids and Related Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.3 Asia-Pacific Autacoids and Related Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.4 South America Autacoids and Related Drugs Sales Breakdown by Application (2021-2026)
  18. 5.3.5 Middle East and Africa Autacoids and Related Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Autacoids and Related Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Autacoids and Related Drugs Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Fresenius
  14. 6.3.1 Fresenius Company Information
  15. 6.3.2 Fresenius Business Overview
  16. 6.3.3 Fresenius Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Autacoids and Related Drugs Product Portfolio
  18. 6.3.5 Fresenius Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Autacoids and Related Drugs Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Bedford Laboratories
  26. 6.5.1 Bedford Laboratories Company Information
  27. 6.5.2 Bedford Laboratories Business Overview
  28. 6.5.3 Bedford Laboratories Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bedford Laboratories Autacoids and Related Drugs Product Portfolio
  30. 6.5.5 Bedford Laboratories Recent Developments
  31. 6.6 Abbott Laboratories
  32. 6.6.1 Abbott Laboratories Company Information
  33. 6.6.2 Abbott Laboratories Business Overview
  34. 6.6.3 Abbott Laboratories Autacoids and Related Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Abbott Laboratories Autacoids and Related Drugs Product Portfolio
  36. 6.6.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Autacoids and Related Drugs Sales by Country
  2. 7.1.1 North America Autacoids and Related Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Autacoids and Related Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Autacoids and Related Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Autacoids and Related Drugs Market Size by Country
  6. 7.2.1 North America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Autacoids and Related Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Autacoids and Related Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Autacoids and Related Drugs Sales by Country
  2. 8.1.1 Europe Autacoids and Related Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Autacoids and Related Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Autacoids and Related Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Autacoids and Related Drugs Market Size by Country
  6. 8.2.1 Europe Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Autacoids and Related Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Autacoids and Related Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Autacoids and Related Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Autacoids and Related Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Autacoids and Related Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Autacoids and Related Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Autacoids and Related Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Autacoids and Related Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Autacoids and Related Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Autacoids and Related Drugs Sales by Country
  2. 10.1.1 South America Autacoids and Related Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Autacoids and Related Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Autacoids and Related Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Autacoids and Related Drugs Market Size by Country
  6. 10.2.1 South America Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Autacoids and Related Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Autacoids and Related Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Autacoids and Related Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Autacoids and Related Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Autacoids and Related Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Autacoids and Related Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Autacoids and Related Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Autacoids and Related Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Autacoids and Related Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Autacoids and Related Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Autacoids and Related Drugs Value Chain Analysis
  2. 12.1.1 Autacoids and Related Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Autacoids and Related Drugs Production Mode & Process
  7. 12.2 Autacoids and Related Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Autacoids and Related Drugs Distributors
  10. 12.2.3 Autacoids and Related Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst